Swara Baby Products secures SEBI approval for Rs 1,000 crore IPO

Swara Baby Products, India’s largest contract manufacturer of disposable hygiene products, has received approval from the Securities and Exchange Board of India (SEBI) for its Rs 1,000 crore initial public offering (IPO). The IPO includes a Rs 500 crore fresh issue and an offer for sale, with proceeds earmarked for expansion and debt repayment.

SEBI approval for Rs 1,000 crore IPO

According to Entrackr, Swara Baby Products has received approval from the Securities and Exchange Board of India (SEBI) for its Rs 1,000 crore initial public offering (IPO). The IPO is structured as a combination of a Rs 500 crore fresh issue of shares and a Rs 500 crore offer for sale (OFS). This approval marks a critical milestone for the company as it prepares to enter the public markets.

Stakeholder participation and fund allocation

The offer for sale includes significant participation from existing stakeholders. Brainbees Solutions, the parent company of FirstCry, plans to sell shares worth Rs 300 crore, while Anadya Bon Merchari LLP will offload shares worth Rs 200 crore. The proceeds from the fresh issue will be allocated toward several strategic initiatives, including the establishment of a new manufacturing facility.

Swara Baby Products also intends to use Rs 100 crore of the proceeds to repay existing borrowings. Additionally, Rs 27.5 crore will be invested in its subsidiaries—Solis Hygiene, Swara Hygiene, and KAEHPL—for debt repayment. The remaining funds will be directed toward potential acquisitions and general corporate purposes.

The company may also consider a pre-IPO placement of up to Rs 100 crore, pending consultation with its bankers.

Market leadership and financial performance

Swara Baby Products is India’s largest contract manufacturer of disposable hygiene products by value, a position it held in FY25. The company specializes in manufacturing baby diapers, adult diapers, sanitary napkins, and panty liners, serving major brands such as Piramal Pharma and Himalaya Wellness. Its Cuddles brand for baby diapers and Shield brand for adult diapers are among its key offerings.

In FY25, Swara Baby held a 37% share of the baby diaper contract manufacturing market and an estimated 36% share of the adult diaper segment. The company’s financial performance reflects its market dominance, with operating revenue growing 23% to Rs 1,163.9 crore in FY26. Profit for the same period rose 18% to Rs 95.58 crore, while EBITDA reached Rs 192.77 crore, up from Rs 162.72 crore in FY25.

Advisors and next steps

JM Financial and Avendus Capital are serving as the book-running lead managers for the IPO. The company’s progression toward a public listing underscores its growth trajectory and ambitions to expand its manufacturing capabilities and market reach.

What this means

Lazyfounder analysis — our interpretation, not reported fact.

Swara Baby Products’ SEBI approval for a Rs 1,000 crore IPO highlights the growing appetite for public listings among India’s contract manufacturers, a sector often overshadowed by consumer-facing brands. The move reflects confidence in the long-term demand for disposable hygiene products, driven by rising hygiene awareness and affordability in India.

For founders and operators, this IPO is a case study in scaling a B2B business. Swara Baby’s success as a contract manufacturer—serving brands without building its own consumer identity—demonstrates how specialized players can carve out dominate market positions. The allocation of IPO proceeds toward expansion and debt repayment also signals a strategic focus on scaling operations, which could inspire similar businesses to explore public markets.

However, the IPO’s dual structure—a fresh issue combined with a substantial offer for sale—suggests that early investors and stakeholders are seizing an opportunity to monetize their holdings. This could set a precedent for other contract manufacturers eyeing public listings, particularly those in high-growth sectors like hygiene and personal care.

Key takeaways

• SEBI has approved Swara Baby Products’ Rs 1,000 crore IPO, marking a significant step for India’s hygiene manufacturing sector.
• The IPO includes a Rs 500 crore fresh issue and a Rs 500 crore offer for sale, with proceeds earmarked for expansion and debt reduction.
• Swara Baby is a market leader in contract manufacturing for disposable hygiene products, serving brands like Piramal Pharma and Himalaya Wellness.
• Financial growth is strong, with revenue and profit rising in FY26, reflecting increasing demand for hygiene products.
• The IPO could set a benchmark for contract manufacturers seeking public listings in India.

FAQ

What is Swara Baby Products’ core business?

Swara Baby Products is a contract manufacturer of disposable hygiene products, including baby diapers, adult diapers, sanitary napkins, and panty liners. It also sells products under its own brands, Cuddles and Shield.

How will the IPO proceeds be used?

The fresh issue proceeds of Rs 500 crore will be allocated toward setting up a new manufacturing facility, repaying debt, investing in subsidiaries for debt repayment, and funding acquisitions and general corporate purposes.

Who are the key stakeholders selling shares in the IPO?

Brainbees Solutions, the parent company of FirstCry, will sell shares worth Rs 300 crore, while Anadya Bon Merchari LLP will offload shares worth Rs 200 crore as part of the offer for sale.

What is Swara Baby’s market position?

Swara Baby was India’s largest hygiene contract manufacturer by value in FY25, holding a 37% share in the baby diaper segment and an estimated 36% share in adult diapers.

Who are the book-running lead managers for the IPO?

JM Financial and Avendus Capital are the book-running lead managers for Swara Baby Products’ IPO.

Related on Lazyfounder

• More business news